Article Details
Retrieved on: 2022-12-31 11:41:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 7,495,924 shares of the biopharmaceutical company's stock worth $136,426,000 after acquiring an additional 144,999 shares ...
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here